Literature DB >> 1889415

Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes.

M Maurice1, S Emiliani, I Dalet-Beluche, J Derancourt, R Lange.   

Abstract

Antibodies raised against cytochrome P450, which is overexpressed in mouse hepatic tumors, (P450tu) crossreact with two human liver microsomal proteins (49 kDa and 52 kDa). We have quantified these proteins in 60 human liver samples and found great interindividual variability in both of them. The concentration of the 49-kDa protein varies up to 144 fold in the various samples and represents typically 10% of the total mincrosomal P450 content. Its immunologically determined concentration correlates well (R = 0.78) with the microsomal coumarin-7-hydroylase (COH) activity. This activity is strongly and completely inhibited by anti-P450tu antibody (IC50 = 0.13 mg IgG/mg microsomal protein). The crossreacting 49-kDa protein shows an unusually high substrate specificity towards coumarin; it presents all human COH and part of 7-ethoxycoumarin O-deethylase (ECOD). Besides these two activities, we did not find any activity with other typical P450 substrates. In primary cultures of human hepatocytes, it is inducible by phenobarbital and dexamethasone, but not by pyrazole and beta-naphthoflavone. We isolated this protein from human liver microsomes and purified it to homogeneity by a combination of aminooctyl-amino-Sepharose chromatography and immunoaffinity chromatography. The protein was identified as a cytochrome P450 of the IIA subfamily. Its N-terminal amino-acid sequence was identical with the first 20 residues deduced from the nucleotide sequence of P450IIA6.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889415     DOI: 10.1111/j.1432-1033.1991.tb16212.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.

Authors:  R Hyland; E G Roe; B C Jones; D A Smith
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

2.  Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.

Authors:  Julie-Anne Tanner; Bhagwat Prasad; Katrina G Claw; Patricia Stapleton; Amarjit Chaudhry; Erin G Schuetz; Kenneth E Thummel; Rachel F Tyndale
Journal:  J Pharmacol Exp Ther       Date:  2016-11-04       Impact factor: 4.030

3.  In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Authors:  Natasa Djordjevic; Juan Antonio Carrillo; Guillermo Gervasini; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

4.  Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.

Authors:  S J Baldwin; S E Clarke; R J Chenery
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

5.  Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity.

Authors:  Jianhua Li; Zahir Hussain; Junjie Zhu; Saifei Lei; Jie Lu; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2021-11-17       Impact factor: 3.739

6.  Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors.

Authors:  Nael Al Koudsi; Ewa B Hoffmann; Abbas Assadzadeh; Rachel F Tyndale
Journal:  Eur J Clin Pharmacol       Date:  2009-12-09       Impact factor: 2.953

7.  A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.

Authors:  P Fernandez-Salguero; S M Hoffman; S Cholerton; H Mohrenweiser; H Raunio; A Rautio; O Pelkonen; J D Huang; W E Evans; J R Idle
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

8.  Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.

Authors:  J C Bloomer; S J Baldwin; G J Smith; A D Ayrton; S E Clarke; R J Chenery
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

Review 9.  Variation in CYP2A6 Activity and Personalized Medicine.

Authors:  Julie-Anne Tanner; Rachel F Tyndale
Journal:  J Pers Med       Date:  2017-12-01

10.  Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts.

Authors:  G Smith; D J Harrison; N East; F Rae; H Wolf; C R Wolf
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.